McKinsey's advisory work for Purdue Pharma centered on aggressively promoting OxyContin amid an escalating opioid addiction crisis, resulting in significant public health consequences.
In an unprecedented move, McKinsey has issued an apology for its collaboration with Purdue Pharma, acknowledging the deep societal harm caused by opioids and expressing regret.
The settlement highlights a critical accountability shift, where McKinsey agreed to pay $650 million without admitting wrongdoing, marking a historical moment of recognizing operational ethics failures.
Martin Elling's guilty plea for obstruction of justice underscores the serious legal ramifications faced by individuals at the firm due to their involvement with Purdue Pharma.
Collection
[
|
...
]